Medications

Actemra approved for certain blood vessel inflammation

(HealthDay)—The injected drug Actemra (tocilizumab) has been approved by the U.S. Food and Drug Administration to treat adults with giant cell arteritis, an inflammation of the blood vessels (vasculitis).

Immunology

Researchers unravel abilities of the immune system's giant cells

If rubbish is too big and unwieldy for normal household waste, its removal becomes the job of specialized experts. Researchers from the Technical University of Munich (TUM) have now discovered, in cooperation with colleagues ...

Cardiology

New discovery on Giant Cell Arteritis sheds light on cause

New research from Queen Mary University of London has revealed – for the first time – how the condition Giant Cell Arteritis (GCA) may be caused by a certain group of white blood cells called 'neutrophils'. GCA (also ...

Oncology & Cancer

Denosumab reduces burden of giant-cell tumor of the bone

Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according ...

Medical research

Analyzing tumor cells in blood using nanomagnets

Siemens' researchers have been able to analyze blood cells by employing the same magnetic reading technology as is used for computer hard drives. They have developed a prototype for the magnetic flow cytometry of blood. Blood ...

Arthritis & Rheumatism

Updated: Giant cell arteritis classification criteria

Giant cell arteritis is the most common form of systemic vasculitis in people over the age of 50. It affects large‐ and medium‐sized blood vessels, particularly in the head—although not exclusively. Common symptoms ...

page 2 from 3